James A Tumlin Selected Research

Fenoldopam (Corlopam)

12/2009	Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy.
2/2008	Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
1/2007	Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.
7/2005	Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
11/2003	Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Tumlin Research Topics

Disease

11	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 07/2005
8	Proteinuria 08/2021 - 07/2003
6	IGA Glomerulonephritis (IGA Nephropathy) 11/2020 - 07/2003
4	Renal Insufficiency (Renal Failure) 02/2022 - 07/2005
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2018 - 01/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2011 - 02/2003
2	Chronic Renal Insufficiency 09/2022 - 11/2003
2	Anemia 09/2022 - 11/2018
2	Lupus Nephritis 08/2021 - 08/2008
2	Cardiac Arrhythmias (Arrythmia) 01/2019 - 04/2016
2	Sudden Death 01/2019 - 04/2016
2	Inflammation (Inflammations) 11/2018 - 02/2007
2	Critical Illness (Critically Ill) 09/2013 - 01/2007
2	Hypotension (Low Blood Pressure) 02/2013 - 12/2009
2	Glomerulonephritis 03/2011 - 05/2004
2	Hypertension (High Blood Pressure) 09/2007 - 05/2004
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2007 - 05/2004
2	Fibrosis (Cirrhosis) 02/2007 - 07/2003
1	Hypoxia (Hypoxemia) 09/2022
1	Atrial Fibrillation 02/2022
1	COVID-19 12/2020
1	Albuminuria 11/2018
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2018
1	Shock 01/2018
1	Neoplasms (Cancer) 09/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015
1	Diarrhea 02/2013
1	Hypophosphatemia 02/2013
1	Heart Failure 01/2013
1	Pulmonary Embolism 06/2012
1	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2011
1	Infections 03/2011
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2011
1	Nephrotic Syndrome (Syndrome, Nephrotic) 03/2011
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 03/2011
1	Ischemia 12/2009
1	Disease Progression 09/2007
1	Necrosis 07/2005

Drug/Important Bio-Agent (IBA)

9	CreatinineIBA 08/2021 - 07/2003
5	Fenoldopam (Corlopam)FDA LinkGeneric 12/2009 - 11/2003
3	SteroidsIBA 03/2011 - 07/2003
3	Immunoglobulin A (IgA)IBA 03/2011 - 05/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2008 - 07/2003
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2018
2	abetimusIBA 08/2008 - 02/2003
2	Calcineurin InhibitorsIBA 02/2007 - 01/2006
1	HematinicsIBA 09/2022
1	IronIBA 09/2022
1	vadadustatIBA 09/2022
1	Erythropoietin FDA Link 09/2022
1	Hemoglobins (Hemoglobin)IBA 09/2022
1	Darbepoetin alfa (Aranesp)FDA Link 09/2022
1	Prolyl-Hydroxylase InhibitorsIBA 09/2022
1	Pancreatic Elastase (Elastase)IBA 08/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 08/2021
1	Complement C5 (Complement 5)IBA 08/2021
1	narsoplimabIBA 11/2020
1	ElectrolytesIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	CalciumIBA 01/2019
1	MagnesiumIBA 01/2019
1	PotassiumIBA 01/2019
1	Dialysis SolutionsIBA 01/2019
1	baricitinibIBA 11/2018
1	Janus KinasesIBA 11/2018
1	Angiotensin IIIBA 01/2018
1	AntibodiesIBA 04/2017
1	Rituximab (Mabthera)FDA Link 04/2017
1	Angiotensin Receptor AntagonistsIBA 04/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2017
1	Contrast MediaIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Furosemide (Lasix)FDA LinkGeneric 09/2013
1	Sevelamer (RenaGel)FDA Link 02/2013
1	AngiotensinogenIBA 02/2013
1	DiureticsIBA 01/2013
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2011
1	Vasodilator Agents (Vasodilators)IBA 12/2009
1	ProstaglandinsIBA 11/2009
1	DNA (Deoxyribonucleic Acid)IBA 08/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2008
1	anti-dsDNA autoantibodyIBA 08/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2007
1	CalcineurinIBA 02/2007
1	Protein Isoforms (Isoforms)IBA 02/2007
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Sirolimus (Rapamycin)FDA Link 01/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 07/2005
1	Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric 05/2004
1	Methylprednisolone FDA LinkGeneric 07/2003
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2003

Therapy/Procedure

7	Therapeutics 01/2018 - 07/2003
3	Renal Dialysis (Hemodialysis) 02/2022 - 04/2016
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 01/2007
1	Critical Care (Surgical Intensive Care) 01/2007